rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Kim Caple

Director

Company insider

Files Form 4 as: Director, Castle Biosciences.

In numbers

Trades disclosed
25
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
14 Jul 2021
Last trade
28 May 2026
Last filed
1 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
CSTL Castle BiosciencesDirector · Diagnostics & Labs · last 28 May 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
28 May 2026filed 1 Jun 2026CSTL Castle Biosciencesoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—11,766 at $0.00filing
28 May 2026filed 1 Jun 2026CSTL Castle Biosciencesoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—11,766 at $0.00filing
22 May 2026filed 27 May 2026CSTL Castle BiosciencesDiagnostics & LabsSEC FORM 4 Code M—13,667filing
22 May 2026filed 27 May 2026CSTL Castle Biosciencesoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—13,667 at $0.00filing
22 May 2026filed 27 May 2026CSTL Castle Biosciencesoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—13,667 at $0.00filing
22 May 2026filed 27 May 2026CSTL Castle BiosciencesDiagnostics & LabsSEC FORM 4 Code M—13,667filing
22 May 2025filed 23 May 2025CSTL Castle Biosciencesoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—13,667 at $0.00filing
21 May 2025filed 23 May 2025CSTL Castle Biosciencesoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—8,673 at $0.00filing
21 May 2025filed 23 May 2025CSTL Castle BiosciencesDiagnostics & LabsSEC FORM 4 Code M—8,673filing
14 Jul 2024filed 16 Jul 2024CSTL Castle Biosciencesoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—440 at $0.00filing
14 Jul 2024filed 16 Jul 2024CSTL Castle BiosciencesDiagnostics & LabsSEC FORM 4 Code M—440filing
25 May 2024filed 29 May 2024CSTL Castle Biosciencesoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—8,636 at $0.00filing
25 May 2024filed 29 May 2024CSTL Castle BiosciencesDiagnostics & LabsSEC FORM 4 Code M—8,636filing
23 May 2024filed 28 May 2024CSTL Castle Biosciencesoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—8,673 at $0.00filing
14 Jul 2023filed 18 Jul 2023CSTL Castle Biosciencesoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—440 at $0.00filing
14 Jul 2023filed 18 Jul 2023CSTL Castle BiosciencesDiagnostics & LabsSEC FORM 4 Code M—440filing
2 Jun 2023filed 6 Jun 2023CSTL Castle Biosciencesoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—3,825 at $0.00filing
2 Jun 2023filed 6 Jun 2023CSTL Castle BiosciencesDiagnostics & LabsSEC FORM 4 Code M—3,825filing
25 May 2023filed 30 May 2023CSTL Castle Biosciencesoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—8,636 at $0.00filing
14 Jul 2022filed 18 Jul 2022CSTL Castle Biosciencesoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—440 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Tobin W. JuvenalChief Commercial Officer · Chief Commercial Officer at Castle Biosciences, filing Form 4 there in the last year
Derek J. MaetzoldPres. & Chief Exec. Officer · Pres. & Chief Exec. Officer at Castle Biosciences, filing Form 4 there in the last year
Kristen M. OelschlagerChief Operating Officer · Chief Operating Officer at Castle Biosciences, filing Form 4 there in the last year
Frank StokesChief Financial Officer · Chief Financial Officer at Castle Biosciences, filing Form 4 there in the last year
Ellen GoldbergDirector · Director at Castle Biosciences, filing Form 4 there in the last year